
Keytruda: Uses, Dosage, Side Effects, Warnings - Drugs.com
Oct 2, 2025 · Keytruda is an immunotherapy treatment used to treat multiple cancers, including melanoma, non-small cell lung cancer, head and neck cancer, breast cancer, and many others. …
KEYTRUDA® (pembrolizumab) - Official Site
Common side effects of KEYTRUDA when given with certain chemotherapy or chemotherapy with radiation therapy medicines include feeling tired or weak; nausea; constipation; diarrhea; decreased …
Pembrolizumab - Wikipedia
Pembrolizumab, sold under the brand name Keytruda, is a humanized monoclonal antibody, more specifically a PD-1 inhibitor, used in cancer immunotherapy to treat many types of cancer. [12][14] It …
Keytruda (pembrolizumab): Side effects, uses, cost, and more
Aug 21, 2025 · Keytruda is a brand-name infusion approved to treat several types of cancer. Learn about side effects, warnings, dosage, and more.
KEYTRUDA is indicated for the treatment of adult and pediatric patients with refractory primary mediastinal large B-cell lymphoma (PMBCL), or who have relapsed after 2 or more prior lines of …
Keytruda - Chemocare
Keytruda - Pembrolizumab Injection What is this medication? PEMBROLIZUMAB (PEM broe LIZ ue mab) treats some types of cancer. It works by helping your immune system slow or stop the spread …
Keytruda (pembrolizumab): Cancer Chemo Drug Uses & Side Effects
Keytruda (pembrolizumab) is a cancer chemotherapy drug that treats melanoma, lung cancer, and a host of other malignancies. It is often used in combination with other chemotherapy agents, …
Keytruda | European Medicines Agency (EMA)
Keytruda, in combination with carboplatin and paclitaxel, is indicated for the first-line treatment of primary advanced or recurrent endometrial carcinoma in adults who are candidates for systemic …
Keytruda (pembrolizumab) dosing, indications, interactions, adverse ...
Medscape - Cancer dosing for Keytruda (pembrolizumab), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and cost information.
FDA Approves Keytruda and Padcev for Muscle Invasive Bladder Cancer
13 hours ago · Keytruda and Padcev improve event-free and overall survival for adults with muscle invasive bladder cancer who cannot receive cisplatin after surgery.